Masitinib can help patients by slowing down the progression of Expanded Disability Status Scale (EDSS)-based impairment. Multiple Sclerosis (MS) is a degenerative, demyelinating, and inflammatory disease of the central nervous system. In terms of medication, the clinical course of MS is diverse, with patients falling into two major categories. The first group, relapsing disease, is...